EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Inflammation, metabolism, and aging in heart failure with preserved ejection fraction: Mechanisms and treatment perspectives

Yaqun Teng, Weikang Bian, Qingyu Li, Jennifer E Van Eyk, Xiaowei Yan iD, Shuyang Zhang iD

Journal of Translational Internal Medicine · 25.06.2026 · 14 (3) · 379-397

DOI: 10.1515/jtim-2026-0043 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Translational Internal Medicine, online erschienen am 13.06.2026. Verfasst von Yaqun Teng und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, State Key Laboratory of Complex Severe and Rare disease, Peking Union Medical College Hospital, Chinese Academy of Medical …. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 172 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Heart failure with preserved ejection fraction (HFpEF) is an increasingly prevalent clinical syndrome with limited effective therapies, representing a major unmet need in cardiovascular medicine. A comorbidity-driven systemic proinflammatory state, together with coronary microvascular endothelial inflammation, has emerged as a central paradigm in HFpEF pathogenesis. Accumulating evidence over the past decade has highlighted the extensive crosstalk between inflammation, metabolic dysregulation, and aging-related processes. In this review, we summarize key advances defining the roles of systemic and microvascular inflammation, metabolic abnormalities, and cellular senescence, and integrate these findings into an interconnected inflammation–metabolism–aging axis in HFpEF. We further discuss the current clinical and emerging preclinical therapeutic strategies targeting these pathways. By linking mechanistic insights with translational perspectives, this review provides a conceptual framework to guide precise therapeutic development for this complex and heterogeneous syndrome.

Schlagwörter

Stichwörter der Autor:innen

agingheart failure with preserved ejection fractionmetabolic remodelingmicrovascular inflammationtranslational medicine

Autor:innen und Institutionen

  • Department of Cardiology, State Key Laboratory of Complex Severe and Rare disease, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
  • Department of Internal Medicine, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
  • Advanced Clinical Biosystems Research Institute, Smidt Heart Institute, Cedars-Sinai Medical Center, Los Angeles, CA, USA.
  • School of Medicine, Tsinghua Medicine, Tsinghua University, Beijing, China.

ORCID-Profile: Xiaowei Yan, Shuyang Zhang

Zitieren

APA

Teng, Y., Bian, W., Li, Q., Eyk, J. E. V., Yan, X., & Zhang, S. (2026). Inflammation, metabolism, and aging in heart failure with preserved ejection fraction: Mechanisms and treatment perspectives. Journal of Translational Internal Medicine, 14(3), 379-397. https://doi.org/10.1515/jtim-2026-0043

Vancouver

Teng Y, Bian W, Li Q, Eyk JEV, Yan X, Zhang S. Inflammation, metabolism, and aging in heart failure with preserved ejection fraction: Mechanisms and treatment perspectives. Journal of Translational Internal Medicine. 2026;14(3):379-397. doi:10.1515/jtim-2026-0043

BibTeX
@article{Teng2026,
  author = {Teng, Yaqun and Bian, Weikang and Li, Qingyu and Eyk, Jennifer E Van and Yan, Xiaowei and Zhang, Shuyang},
  title = {Inflammation, metabolism, and aging in heart failure with preserved ejection fraction: Mechanisms and treatment perspectives},
  journal = {Journal of Translational Internal Medicine},
  year = {2026},
  volume = {14},
  number = {3},
  pages = {379--397},
  doi = {10.1515/jtim-2026-0043}
}
Kostenlos starten →